Seoul, South Korea

Sung-Ju Choi

USPTO Granted Patents = 1 


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovative Contributions of Sung-Ju Choi in Ophthalmic Medicine**

Introduction

Sung-Ju Choi, a prominent inventor based in Seoul, South Korea, has made significant strides in the field of ophthalmology. With a focus on innovative solutions for eye care, Choi has developed a patented ophthalmic composition that addresses the needs of patients suffering from dry eye syndrome.

Latest Patents

Choi holds a patent for an "Ophthalmic composition comprising rebamipide and method for preparing the same." This groundbreaking composition maintains its transparency for an extended period, even in physiologically neutral to weakly basic pH ranges. Importantly, it ensures that it does not injure the cornea and conjunctiva of patients, thereby providing a safe solution for those affected by dry eyes. The invention also boasts enhanced stability that prevents re-dispersion.

Career Highlights

Sung-Ju Choi is currently associated with Samjin Pharmaceutical Co., Ltd., a company known for its commitment to developing innovative medical products. His work there emphasizes the advancement of ophthalmic treatments and showcases his dedication to improving patient outcomes.

Collaborations

Throughout his career, Choi has collaborated with notable colleagues, including Eui-Hwan Cho and Sung-Woo Lee. Their teamwork and shared vision have contributed to the success of their projects and have further influenced advancements in ophthalmic formulations.

Conclusion

Sung-Ju Choi’s contributions to ophthalmic medicine illustrate the impact of innovation in enhancing patient care. His patented formulation and collaborative efforts at Samjin Pharmaceutical Co., Ltd. showcase his commitment to addressing challenges in eye health, ultimately leading to better solutions for individuals suffering from dry eye conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…